No Data
PepGen Stock Craters 35% on FDA Clinical Hold
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
We Ran A Stock Scan For Earnings Growth And Catalyst Pharmaceuticals (NASDAQ:CPRX) Passed With Ease
Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List
Catalyst Pharmaceuticals(CPRX.US) Director Sells US$3.63 Million in Common Stock
$Catalyst Pharmaceuticals(CPRX.US)$ Director MCENANY PATRICK J sold 170.85K shares of common stock on Nov 19, 20, 2024 at an average price of $21.231 for a total value of $3.63 million.Source:
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences